THERAPEUTIC AREAS OF INTEREST

Cardiovascular

  • Vascular Protection (CAD/PAD) and anticoagulation treatment
  • Age /Frailty and use of NOACs
  • Obesity and the use of NOACs
  • Stroke Prevention in Atrial Fibrillation with NOACs

Metabolism

  • Not accepting applications at this time
  • Type 2 Diabetes Mellitus
  • Renal Disease

Neuroscience

  • Schizophrenia
  • Major Depressive Disorder (including Treatment Resistant Depression)